#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=3. Protein and Peptide Nanobiosensors for the Early Diagnosis of Diseases
1-1	0-2	3.	_	_	_	_
1-2	3-10	Protein	substance|abstract[3]	new|new[3]	coref|coref	5-16[0_3]|6-5
1-3	11-14	and	abstract[3]	new[3]	_	_
1-4	15-22	Peptide	abstract|abstract[3]	new|new[3]	coref	15-26
1-5	23-37	Nanobiosensors	abstract[3]	new[3]	_	_
1-6	38-41	for	abstract[3]	new[3]	_	_
1-7	42-45	the	abstract[3]|abstract[4]	new[3]|new[4]	coref	4-12[27_4]
1-8	46-51	Early	abstract[3]|abstract[4]	new[3]|new[4]	_	_
1-9	52-61	Diagnosis	abstract[3]|abstract[4]	new[3]|new[4]	_	_
1-10	62-64	of	abstract[3]|abstract[4]	new[3]|new[4]	_	_
1-11	65-73	Diseases	abstract[3]|abstract[4]|abstract	new[3]|new[4]|new	coref	4-16

#Text=A pathological process at an early stage is characterized by the appearance of marker proteins at very low ( 10−15 M and lower ) concentrations in blood , and highly-sensitive nanobiosensor systems are required to detect proteins at such low concentrations .
2-1	74-75	A	abstract[6]	new[6]	_	_
2-2	76-88	pathological	abstract[6]	new[6]	_	_
2-3	89-96	process	abstract[6]	new[6]	_	_
2-4	97-99	at	abstract[6]	new[6]	_	_
2-5	100-102	an	abstract[6]|time[7]	new[6]|new[7]	_	_
2-6	103-108	early	abstract[6]|time[7]	new[6]|new[7]	_	_
2-7	109-114	stage	abstract[6]|time[7]	new[6]|new[7]	_	_
2-8	115-117	is	_	_	_	_
2-9	118-131	characterized	_	_	_	_
2-10	132-134	by	_	_	_	_
2-11	135-138	the	abstract[8]	new[8]	_	_
2-12	139-149	appearance	abstract[8]	new[8]	_	_
2-13	150-152	of	abstract[8]	new[8]	_	_
2-14	153-159	marker	abstract[8]|abstract|substance[10]	new[8]|new|new[10]	coref|coref	2-37[0_10]|14-32[203_0]
2-15	160-168	proteins	abstract[8]|substance[10]	new[8]|new[10]	_	_
2-16	169-171	at	abstract[8]|substance[10]	new[8]|new[10]	_	_
2-17	172-176	very	abstract[8]|substance[10]|abstract[12]	new[8]|new[10]|new[12]	coref	2-39[17_12]
2-18	177-180	low	abstract[8]|substance[10]|abstract[12]	new[8]|new[10]|new[12]	_	_
2-19	181-182	(	abstract[8]|substance[10]|abstract[12]	new[8]|new[10]|new[12]	_	_
2-20	183-188	10−15	abstract[8]|substance[10]|abstract[11]|abstract[12]	new[8]|new[10]|new[11]|new[12]	_	_
2-21	189-190	M	abstract[8]|substance[10]|abstract[11]|abstract[12]	new[8]|new[10]|new[11]|new[12]	_	_
2-22	191-194	and	abstract[8]|substance[10]|abstract[12]	new[8]|new[10]|new[12]	_	_
2-23	195-200	lower	abstract[8]|substance[10]|abstract[12]	new[8]|new[10]|new[12]	_	_
2-24	201-202	)	abstract[8]|substance[10]|abstract[12]	new[8]|new[10]|new[12]	_	_
2-25	203-217	concentrations	abstract[8]|substance[10]|abstract[12]	new[8]|new[10]|new[12]	_	_
2-26	218-220	in	abstract[8]|substance[10]|abstract[12]	new[8]|new[10]|new[12]	_	_
2-27	221-226	blood	abstract[8]|substance[10]|abstract[12]|substance	new[8]|new[10]|new[12]|new	_	_
2-28	227-228	,	_	_	_	_
2-29	229-232	and	_	_	_	_
2-30	233-249	highly-sensitive	object[15]	new[15]	coref	17-7[237_15]
2-31	250-263	nanobiosensor	organization|object[15]	new|new[15]	_	_
2-32	264-271	systems	object[15]	new[15]	_	_
2-33	272-275	are	_	_	_	_
2-34	276-284	required	_	_	_	_
2-35	285-287	to	_	_	_	_
2-36	288-294	detect	_	_	_	_
2-37	295-303	proteins	substance	giv	coref	5-62[53_0]
2-38	304-306	at	_	_	_	_
2-39	307-311	such	abstract[17]	giv[17]	coref	6-7[64_17]
2-40	312-315	low	abstract[17]	giv[17]	_	_
2-41	316-330	concentrations	abstract[17]	giv[17]	_	_
2-42	331-332	.	_	_	_	_

#Text=Additionally , the composition of biomolecules gathering at a surface is another relevant issue , given the dynamic nature of disease progression .
3-1	333-345	Additionally	_	_	_	_
3-2	346-347	,	_	_	_	_
3-3	348-351	the	abstract[18]	new[18]	coref	3-12[21_18]
3-4	352-363	composition	abstract[18]	new[18]	_	_
3-5	364-366	of	abstract[18]	new[18]	_	_
3-6	367-379	biomolecules	abstract[18]|substance[19]	new[18]|new[19]	_	_
3-7	380-389	gathering	abstract[18]|substance[19]	new[18]|new[19]	_	_
3-8	390-392	at	abstract[18]|substance[19]	new[18]|new[19]	_	_
3-9	393-394	a	abstract[18]|substance[19]|place[20]	new[18]|new[19]|new[20]	coref	11-27[0_20]
3-10	395-402	surface	abstract[18]|substance[19]|place[20]	new[18]|new[19]|new[20]	_	_
3-11	403-405	is	_	_	_	_
3-12	406-413	another	abstract[21]	giv[21]	coref	12-24[172_21]
3-13	414-422	relevant	abstract[21]	giv[21]	_	_
3-14	423-428	issue	abstract[21]	giv[21]	_	_
3-15	429-430	,	abstract[21]	giv[21]	_	_
3-16	431-436	given	abstract[21]	giv[21]	_	_
3-17	437-440	the	abstract[21]|abstract[22]	giv[21]|new[22]	_	_
3-18	441-448	dynamic	abstract[21]|abstract[22]	giv[21]|new[22]	_	_
3-19	449-455	nature	abstract[21]|abstract[22]	giv[21]|new[22]	_	_
3-20	456-458	of	abstract[21]|abstract[22]	giv[21]|new[22]	_	_
3-21	459-466	disease	abstract[21]|abstract[22]|abstract|abstract[24]	giv[21]|new[22]|new|new[24]	_	_
3-22	467-478	progression	abstract[21]|abstract[22]|abstract[24]	giv[21]|new[22]|new[24]	_	_
3-23	479-480	.	_	_	_	_

#Text=With respect to that , nano-biosensors may offer increased possibilities for the early diagnosis of diseases .
4-1	481-485	With	_	_	_	_
4-2	486-493	respect	_	_	_	_
4-3	494-496	to	_	_	_	_
4-4	497-501	that	_	_	_	_
4-5	502-503	,	_	_	_	_
4-6	504-519	nano-biosensors	object	new	_	_
4-7	520-523	may	_	_	_	_
4-8	524-529	offer	_	_	_	_
4-9	530-539	increased	abstract[26]	new[26]	_	_
4-10	540-553	possibilities	abstract[26]	new[26]	_	_
4-11	554-557	for	abstract[26]	new[26]	_	_
4-12	558-561	the	abstract[26]|abstract[27]	new[26]|giv[27]	_	_
4-13	562-567	early	abstract[26]|abstract[27]	new[26]|giv[27]	_	_
4-14	568-577	diagnosis	abstract[26]|abstract[27]	new[26]|giv[27]	_	_
4-15	578-580	of	abstract[26]|abstract[27]	new[26]|giv[27]	_	_
4-16	581-589	diseases	abstract[26]|abstract[27]|abstract	new[26]|giv[27]|giv	_	_
4-17	590-591	.	_	_	_	_

#Text=In the manuscript : Influence of Chip Materials on Charge Generation in Flowing Solution in Nanobiosensors , Y.D. Ivanov and coworkers demonstrate that the presence of an AFM chip ( made of mica and graphite ) near the nozzle of the injector supplying an analyte solution into the measuring cell of an AFM-based fishing system ( used for the registration of low-abundant proteins in the temperature range corresponding to the physiological temperature of 35 ° C ) causes an increase in charge generation upon the injection of the solution .
5-1	592-594	In	_	_	_	_
5-2	595-598	the	abstract[29]	new[29]	appos	5-5[30_29]
5-3	599-609	manuscript	abstract[29]	new[29]	_	_
5-4	610-611	:	_	_	_	_
5-5	612-621	Influence	abstract[30]	giv[30]	_	_
5-6	622-624	of	abstract[30]	giv[30]	_	_
5-7	625-629	Chip	abstract[30]|person|substance[32]	giv[30]|new|new[32]	_	_
5-8	630-639	Materials	abstract[30]|substance[32]	giv[30]|new[32]	_	_
5-9	640-642	on	abstract[30]	giv[30]	_	_
5-10	643-649	Charge	abstract[30]|person|abstract[34]	giv[30]|new|new[34]	coref	5-82[59_34]
5-11	650-660	Generation	abstract[30]|abstract[34]	giv[30]|new[34]	_	_
5-12	661-663	in	abstract[30]|abstract[34]	giv[30]|new[34]	_	_
5-13	664-671	Flowing	abstract[30]|abstract[34]|abstract[35]	giv[30]|new[34]|new[35]	_	_
5-14	672-680	Solution	abstract[30]|abstract[34]|abstract[35]	giv[30]|new[34]|new[35]	_	_
5-15	681-683	in	abstract[30]|abstract[34]	giv[30]|new[34]	_	_
5-16	684-698	Nanobiosensors	abstract[30]|abstract[34]|abstract	giv[30]|new[34]|giv	_	_
5-17	699-700	,	_	_	_	_
5-18	701-705	Y.D.	person	new	_	_
5-19	706-712	Ivanov	person	new	_	_
5-20	713-716	and	_	_	_	_
5-21	717-726	coworkers	person	new	coref	7-4[71_0]
5-22	727-738	demonstrate	_	_	_	_
5-23	739-743	that	_	_	_	_
5-24	744-747	the	abstract[40]	new[40]	_	_
5-25	748-756	presence	abstract[40]	new[40]	_	_
5-26	757-759	of	abstract[40]	new[40]	_	_
5-27	760-762	an	abstract[40]|object[42]	new[40]|new[42]	_	_
5-28	763-766	AFM	abstract[40]|abstract|object[42]	new[40]|new|new[42]	coref	11-66
5-29	767-771	chip	abstract[40]|object[42]	new[40]|new[42]	_	_
5-30	772-773	(	abstract[40]|object[42]	new[40]|new[42]	_	_
5-31	774-778	made	abstract[40]|object[42]	new[40]|new[42]	_	_
5-32	779-781	of	abstract[40]|object[42]	new[40]|new[42]	_	_
5-33	782-786	mica	abstract[40]|object[42]|place	new[40]|new[42]|new	_	_
5-34	787-790	and	abstract[40]|object[42]	new[40]|new[42]	_	_
5-35	791-799	graphite	abstract[40]|object[42]|substance	new[40]|new[42]|new	_	_
5-36	800-801	)	abstract[40]|object[42]	new[40]|new[42]	_	_
5-37	802-806	near	abstract[40]|object[42]	new[40]|new[42]	_	_
5-38	807-810	the	abstract[40]|object[42]|object[45]	new[40]|new[42]|new[45]	_	_
5-39	811-817	nozzle	abstract[40]|object[42]|object[45]	new[40]|new[42]|new[45]	_	_
5-40	818-820	of	abstract[40]|object[42]|object[45]	new[40]|new[42]|new[45]	_	_
5-41	821-824	the	abstract[40]|object[42]|object[45]|object[46]	new[40]|new[42]|new[45]|new[46]	coref	6-19[69_46]
5-42	825-833	injector	abstract[40]|object[42]|object[45]|object[46]	new[40]|new[42]|new[45]|new[46]	_	_
5-43	834-843	supplying	abstract[40]|object[42]|object[45]|object[46]	new[40]|new[42]|new[45]|new[46]	_	_
5-44	844-846	an	abstract[40]|object[42]|object[45]|object[46]|substance[48]	new[40]|new[42]|new[45]|new[46]|new[48]	coref	5-88[61_48]
5-45	847-854	analyte	abstract[40]|object[42]|object[45]|object[46]|abstract|substance[48]	new[40]|new[42]|new[45]|new[46]|new|new[48]	_	_
5-46	855-863	solution	abstract[40]|object[42]|object[45]|object[46]|substance[48]	new[40]|new[42]|new[45]|new[46]|new[48]	_	_
5-47	864-868	into	abstract[40]|object[42]|object[45]|object[46]	new[40]|new[42]|new[45]|new[46]	_	_
5-48	869-872	the	abstract[40]|object[42]|object[45]|object[46]|object[49]	new[40]|new[42]|new[45]|new[46]|new[49]	_	_
5-49	873-882	measuring	abstract[40]|object[42]|object[45]|object[46]|object[49]	new[40]|new[42]|new[45]|new[46]|new[49]	_	_
5-50	883-887	cell	abstract[40]|object[42]|object[45]|object[46]|object[49]	new[40]|new[42]|new[45]|new[46]|new[49]	_	_
5-51	888-890	of	abstract[40]|object[42]|object[45]|object[46]	new[40]|new[42]|new[45]|new[46]	_	_
5-52	891-893	an	abstract[40]|object[42]|object[45]|object[46]|object[51]	new[40]|new[42]|new[45]|new[46]|new[51]	_	_
5-53	894-903	AFM-based	abstract[40]|object[42]|object[45]|object[46]|object[51]	new[40]|new[42]|new[45]|new[46]|new[51]	_	_
5-54	904-911	fishing	abstract[40]|object[42]|object[45]|object[46]|object|object[51]	new[40]|new[42]|new[45]|new[46]|new|new[51]	_	_
5-55	912-918	system	abstract[40]|object[42]|object[45]|object[46]|object[51]	new[40]|new[42]|new[45]|new[46]|new[51]	_	_
5-56	919-920	(	abstract[40]|object[42]|object[45]|object[46]	new[40]|new[42]|new[45]|new[46]	_	_
5-57	921-925	used	abstract[40]|object[42]|object[45]|object[46]	new[40]|new[42]|new[45]|new[46]	_	_
5-58	926-929	for	abstract[40]|object[42]|object[45]|object[46]	new[40]|new[42]|new[45]|new[46]	_	_
5-59	930-933	the	abstract[40]|object[42]|object[45]|object[46]|event[52]	new[40]|new[42]|new[45]|new[46]|new[52]	_	_
5-60	934-946	registration	abstract[40]|object[42]|object[45]|object[46]|event[52]	new[40]|new[42]|new[45]|new[46]|new[52]	_	_
5-61	947-949	of	abstract[40]|object[42]|object[45]|object[46]|event[52]	new[40]|new[42]|new[45]|new[46]|new[52]	_	_
5-62	950-962	low-abundant	abstract[40]|object[42]|object[45]|object[46]|event[52]|substance[53]	new[40]|new[42]|new[45]|new[46]|new[52]|giv[53]	_	_
5-63	963-971	proteins	abstract[40]|object[42]|object[45]|object[46]|event[52]|substance[53]	new[40]|new[42]|new[45]|new[46]|new[52]|giv[53]	_	_
5-64	972-974	in	abstract[40]|object[42]|object[45]|object[46]	new[40]|new[42]|new[45]|new[46]	_	_
5-65	975-978	the	abstract[40]|object[42]|object[45]|object[46]|abstract[55]	new[40]|new[42]|new[45]|new[46]|new[55]	coref	11-45[158_55]
5-66	979-990	temperature	abstract[40]|object[42]|object[45]|object[46]|abstract|abstract[55]	new[40]|new[42]|new[45]|new[46]|new|new[55]	coref	5-70[56_0]
5-67	991-996	range	abstract[40]|object[42]|object[45]|object[46]|abstract[55]	new[40]|new[42]|new[45]|new[46]|new[55]	_	_
5-68	997-1010	corresponding	abstract[40]|object[42]|object[45]|object[46]|abstract[55]	new[40]|new[42]|new[45]|new[46]|new[55]	_	_
5-69	1011-1013	to	abstract[40]|object[42]|object[45]|object[46]|abstract[55]	new[40]|new[42]|new[45]|new[46]|new[55]	_	_
5-70	1014-1017	the	abstract[40]|object[42]|object[45]|object[46]|abstract[55]|abstract[56]	new[40]|new[42]|new[45]|new[46]|new[55]|giv[56]	_	_
5-71	1018-1031	physiological	abstract[40]|object[42]|object[45]|object[46]|abstract[55]|abstract[56]	new[40]|new[42]|new[45]|new[46]|new[55]|giv[56]	_	_
5-72	1032-1043	temperature	abstract[40]|object[42]|object[45]|object[46]|abstract[55]|abstract[56]	new[40]|new[42]|new[45]|new[46]|new[55]|giv[56]	_	_
5-73	1044-1046	of	abstract[40]|object[42]|object[45]|object[46]|abstract[55]|abstract[56]	new[40]|new[42]|new[45]|new[46]|new[55]|giv[56]	_	_
5-74	1047-1049	35	abstract[40]|object[42]|object[45]|object[46]|abstract[55]|abstract[56]|abstract[57]	new[40]|new[42]|new[45]|new[46]|new[55]|giv[56]|new[57]	_	_
5-75	1050-1051	°	abstract[40]|object[42]|object[45]|object[46]|abstract[55]|abstract[56]|abstract[57]	new[40]|new[42]|new[45]|new[46]|new[55]|giv[56]|new[57]	_	_
5-76	1052-1053	C	abstract[40]|object[42]|object[45]|object[46]|abstract[55]|abstract[56]|abstract[57]	new[40]|new[42]|new[45]|new[46]|new[55]|giv[56]|new[57]	_	_
5-77	1054-1055	)	abstract[40]|object[42]|object[45]|object[46]	new[40]|new[42]|new[45]|new[46]	_	_
5-78	1056-1062	causes	_	_	_	_
5-79	1063-1065	an	event[58]	new[58]	coref	6-10[65_58]
5-80	1066-1074	increase	event[58]	new[58]	_	_
5-81	1075-1077	in	event[58]	new[58]	_	_
5-82	1078-1084	charge	event[58]|abstract[59]	new[58]|giv[59]	coref	6-16[68_59]
5-83	1085-1095	generation	event[58]|abstract[59]	new[58]|giv[59]	_	_
5-84	1096-1100	upon	event[58]|abstract[59]	new[58]|giv[59]	_	_
5-85	1101-1104	the	event[58]|abstract[59]|event[60]	new[58]|giv[59]|new[60]	_	_
5-86	1105-1114	injection	event[58]|abstract[59]|event[60]	new[58]|giv[59]|new[60]	_	_
5-87	1115-1117	of	event[58]|abstract[59]|event[60]	new[58]|giv[59]|new[60]	_	_
5-88	1118-1121	the	event[58]|abstract[59]|event[60]|substance[61]	new[58]|giv[59]|new[60]|giv[61]	_	_
5-89	1122-1130	solution	event[58]|abstract[59]|event[60]|substance[61]	new[58]|giv[59]|new[60]|giv[61]	_	_
5-90	1131-1132	.	_	_	_	_

#Text=In the presence of protein at femtomolar concentrations , an increase in the efficiency of charge generation in the injector was demonstrated .
6-1	1133-1135	In	_	_	_	_
6-2	1136-1139	the	abstract[62]	new[62]	_	_
6-3	1140-1148	presence	abstract[62]	new[62]	_	_
6-4	1149-1151	of	abstract[62]	new[62]	_	_
6-5	1152-1159	protein	abstract[62]|substance	new[62]|giv	coref	19-45
6-6	1160-1162	at	abstract[62]	new[62]	_	_
6-7	1163-1173	femtomolar	abstract[62]|abstract[64]	new[62]|giv[64]	_	_
6-8	1174-1188	concentrations	abstract[62]|abstract[64]	new[62]|giv[64]	_	_
6-9	1189-1190	,	_	_	_	_
6-10	1191-1193	an	event[65]	giv[65]	_	_
6-11	1194-1202	increase	event[65]	giv[65]	_	_
6-12	1203-1205	in	event[65]	giv[65]	_	_
6-13	1206-1209	the	event[65]|abstract[66]	giv[65]|new[66]	_	_
6-14	1210-1220	efficiency	event[65]|abstract[66]	giv[65]|new[66]	_	_
6-15	1221-1223	of	event[65]|abstract[66]	giv[65]|new[66]	_	_
6-16	1224-1230	charge	event[65]|abstract[66]|object|abstract[68]	giv[65]|new[66]|new|giv[68]	_	_
6-17	1231-1241	generation	event[65]|abstract[66]|abstract[68]	giv[65]|new[66]|giv[68]	_	_
6-18	1242-1244	in	event[65]|abstract[66]|abstract[68]	giv[65]|new[66]|giv[68]	_	_
6-19	1245-1248	the	event[65]|abstract[66]|abstract[68]|object[69]	giv[65]|new[66]|giv[68]|giv[69]	_	_
6-20	1249-1257	injector	event[65]|abstract[66]|abstract[68]|object[69]	giv[65]|new[66]|giv[68]|giv[69]	_	_
6-21	1258-1261	was	_	_	_	_
6-22	1262-1274	demonstrated	_	_	_	_
6-23	1275-1276	.	_	_	_	_

#Text=G.Z. Gayda and coworkers in their paper on Metallic Nanoparticles Obtained via “ Green ” Synthesis as a Platform for Biosensor Construction demonstrate the possibility of developing reagent-less , enzyme-based amperometric biosensors using metallic nanoparticles obtained via green synthesis ( gNPs ) , which have great potential for applications in biotechnology , industry , and medicine as antibacterial agents , fluorescent markers , and carriers for drug delivery , respectively .
7-1	1277-1281	G.Z.	person[70]	new[70]	_	_
7-2	1282-1287	Gayda	person[70]	new[70]	_	_
7-3	1288-1291	and	_	_	_	_
7-4	1292-1301	coworkers	person[71]	giv[71]	ana	7-6[0_71]
7-5	1302-1304	in	person[71]	giv[71]	_	_
7-6	1305-1310	their	person[71]|person|abstract[73]	giv[71]|giv|new[73]	coref|coref	10-33|13-6[182_73]
7-7	1311-1316	paper	person[71]|abstract[73]	giv[71]|new[73]	_	_
7-8	1317-1319	on	person[71]|abstract[73]	giv[71]|new[73]	_	_
7-9	1320-1328	Metallic	person[71]|abstract[73]|abstract[74]	giv[71]|new[73]|new[74]	coref	13-15[186_74]
7-10	1329-1342	Nanoparticles	person[71]|abstract[73]|abstract[74]	giv[71]|new[73]|new[74]	_	_
7-11	1343-1351	Obtained	person[71]|abstract[73]|abstract[74]	giv[71]|new[73]|new[74]	_	_
7-12	1352-1355	via	person[71]|abstract[73]|abstract[74]	giv[71]|new[73]|new[74]	_	_
7-13	1356-1357	“	person[71]|abstract[73]|abstract[74]|abstract[75]	giv[71]|new[73]|new[74]|new[75]	coref	7-38[82_75]
7-14	1358-1363	Green	person[71]|abstract[73]|abstract[74]|abstract[75]	giv[71]|new[73]|new[74]|new[75]	_	_
7-15	1364-1365	”	person[71]|abstract[73]|abstract[74]|abstract[75]	giv[71]|new[73]|new[74]|new[75]	_	_
7-16	1366-1375	Synthesis	person[71]|abstract[73]|abstract[74]|abstract[75]	giv[71]|new[73]|new[74]|new[75]	_	_
7-17	1376-1378	as	person[71]|abstract[73]|abstract[74]	giv[71]|new[73]|new[74]	_	_
7-18	1379-1380	a	person[71]|abstract[73]|abstract[74]|abstract[76]	giv[71]|new[73]|new[74]|new[76]	_	_
7-19	1381-1389	Platform	person[71]|abstract[73]|abstract[74]|abstract[76]	giv[71]|new[73]|new[74]|new[76]	_	_
7-20	1390-1393	for	person[71]|abstract[73]|abstract[74]|abstract[76]	giv[71]|new[73]|new[74]|new[76]	_	_
7-21	1394-1403	Biosensor	person[71]|abstract[73]|abstract[74]|abstract[76]|place|place[78]	giv[71]|new[73]|new[74]|new[76]|new|new[78]	coref	19-7
7-22	1404-1416	Construction	person[71]|abstract[73]|abstract[74]|abstract[76]|place[78]	giv[71]|new[73]|new[74]|new[76]|new[78]	_	_
7-23	1417-1428	demonstrate	_	_	_	_
7-24	1429-1432	the	abstract[79]	new[79]	_	_
7-25	1433-1444	possibility	abstract[79]	new[79]	_	_
7-26	1445-1447	of	abstract[79]	new[79]	_	_
7-27	1448-1458	developing	abstract[79]	new[79]	_	_
7-28	1459-1471	reagent-less	abstract[79]|abstract[80]	new[79]|new[80]	coref	9-49[0_80]
7-29	1472-1473	,	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-30	1474-1486	enzyme-based	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-31	1487-1499	amperometric	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-32	1500-1510	biosensors	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-33	1511-1516	using	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-34	1517-1525	metallic	abstract[79]|abstract[80]|object[81]	new[79]|new[80]|new[81]	coref	14-7[194_81]
7-35	1526-1539	nanoparticles	abstract[79]|abstract[80]|object[81]	new[79]|new[80]|new[81]	_	_
7-36	1540-1548	obtained	abstract[79]|abstract[80]|object[81]	new[79]|new[80]|new[81]	_	_
7-37	1549-1552	via	abstract[79]|abstract[80]|object[81]	new[79]|new[80]|new[81]	_	_
7-38	1553-1558	green	abstract[79]|abstract[80]|object[81]|abstract[82]	new[79]|new[80]|new[81]|giv[82]	_	_
7-39	1559-1568	synthesis	abstract[79]|abstract[80]|object[81]|abstract[82]	new[79]|new[80]|new[81]|giv[82]	_	_
7-40	1569-1570	(	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-41	1571-1575	gNPs	abstract[79]|abstract[80]|abstract	new[79]|new[80]|new	coref	8-5[96_0]
7-42	1576-1577	)	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-43	1578-1579	,	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-44	1580-1585	which	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-45	1586-1590	have	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-46	1591-1596	great	abstract[79]|abstract[80]|abstract[84]	new[79]|new[80]|new[84]	coref	18-12[246_84]
7-47	1597-1606	potential	abstract[79]|abstract[80]|abstract[84]	new[79]|new[80]|new[84]	_	_
7-48	1607-1610	for	abstract[79]|abstract[80]|abstract[84]	new[79]|new[80]|new[84]	_	_
7-49	1611-1623	applications	abstract[79]|abstract[80]|abstract[84]|abstract[85]	new[79]|new[80]|new[84]|new[85]	coref	14-10[196_85]
7-50	1624-1626	in	abstract[79]|abstract[80]|abstract[84]|abstract[85]	new[79]|new[80]|new[84]|new[85]	_	_
7-51	1627-1640	biotechnology	abstract[79]|abstract[80]|abstract[84]|abstract[85]|abstract	new[79]|new[80]|new[84]|new[85]|new	_	_
7-52	1641-1642	,	abstract[79]|abstract[80]|abstract[84]|abstract[85]	new[79]|new[80]|new[84]|new[85]	_	_
7-53	1643-1651	industry	abstract[79]|abstract[80]|abstract[84]|abstract[85]|abstract	new[79]|new[80]|new[84]|new[85]|new	_	_
7-54	1652-1653	,	abstract[79]|abstract[80]|abstract[84]|abstract[85]	new[79]|new[80]|new[84]|new[85]	_	_
7-55	1654-1657	and	abstract[79]|abstract[80]|abstract[84]|abstract[85]	new[79]|new[80]|new[84]|new[85]	_	_
7-56	1658-1666	medicine	abstract[79]|abstract[80]|abstract[84]|abstract[85]|abstract	new[79]|new[80]|new[84]|new[85]|new	_	_
7-57	1667-1669	as	abstract[79]|abstract[80]|abstract[84]|abstract[85]	new[79]|new[80]|new[84]|new[85]	_	_
7-58	1670-1683	antibacterial	abstract[79]|abstract[80]|abstract[84]|abstract[85]|substance[89]	new[79]|new[80]|new[84]|new[85]|new[89]	_	_
7-59	1684-1690	agents	abstract[79]|abstract[80]|abstract[84]|abstract[85]|substance[89]	new[79]|new[80]|new[84]|new[85]|new[89]	_	_
7-60	1691-1692	,	abstract[79]|abstract[80]|abstract[84]|abstract[85]	new[79]|new[80]|new[84]|new[85]	_	_
7-61	1693-1704	fluorescent	abstract[79]|abstract[80]|abstract[84]|abstract[85]|object[90]	new[79]|new[80]|new[84]|new[85]|new[90]	_	_
7-62	1705-1712	markers	abstract[79]|abstract[80]|abstract[84]|abstract[85]|object[90]	new[79]|new[80]|new[84]|new[85]|new[90]	_	_
7-63	1713-1714	,	abstract[79]|abstract[80]|abstract[84]|abstract[85]	new[79]|new[80]|new[84]|new[85]	_	_
7-64	1715-1718	and	abstract[79]|abstract[80]|abstract[84]|abstract[85]	new[79]|new[80]|new[84]|new[85]	_	_
7-65	1719-1727	carriers	abstract[79]|abstract[80]|abstract[84]|abstract[85]|organization[91]	new[79]|new[80]|new[84]|new[85]|new[91]	coref	9-43[117_91]
7-66	1728-1731	for	abstract[79]|abstract[80]|abstract[84]|abstract[85]|organization[91]	new[79]|new[80]|new[84]|new[85]|new[91]	_	_
7-67	1732-1736	drug	abstract[79]|abstract[80]|abstract[84]|abstract[85]|organization[91]|substance|abstract[93]	new[79]|new[80]|new[84]|new[85]|new[91]|new|new[93]	_	_
7-68	1737-1745	delivery	abstract[79]|abstract[80]|abstract[84]|abstract[85]|organization[91]|abstract[93]	new[79]|new[80]|new[84]|new[85]|new[91]|new[93]	_	_
7-69	1746-1747	,	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-70	1748-1760	respectively	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-71	1761-1762	.	_	_	_	_

#Text=The bioelectrodes modified with Pd-based gNPs have lower sensitivities to their substrates , but broader linear ranges of their detection and higher storage stabilities than unmodified control electrodes .
8-1	1763-1766	The	substance[94]	new[94]	_	_
8-2	1767-1780	bioelectrodes	substance[94]	new[94]	_	_
8-3	1781-1789	modified	substance[94]	new[94]	_	_
8-4	1790-1794	with	substance[94]	new[94]	_	_
8-5	1795-1803	Pd-based	substance[94]|plant|abstract[96]	new[94]|new|giv[96]	coref	9-23[113_96]
8-6	1804-1808	gNPs	substance[94]|abstract[96]	new[94]|giv[96]	_	_
8-7	1809-1813	have	_	_	_	_
8-8	1814-1819	lower	abstract[97]|object[98]	new[97]|new[98]	ana	8-11[0_98]
8-9	1820-1833	sensitivities	abstract[97]|object[98]	new[97]|new[98]	_	_
8-10	1834-1836	to	abstract[97]|object[98]	new[97]|new[98]	_	_
8-11	1837-1842	their	abstract[97]|object[98]|object|substance[100]	new[97]|new[98]|giv|new[100]	ana	8-19
8-12	1843-1853	substrates	abstract[97]|object[98]|substance[100]	new[97]|new[98]|new[100]	_	_
8-13	1854-1855	,	object[98]	new[98]	_	_
8-14	1856-1859	but	object[98]	new[98]	_	_
8-15	1860-1867	broader	object[98]|abstract[101]	new[98]|new[101]	_	_
8-16	1868-1874	linear	object[98]|abstract[101]	new[98]|new[101]	_	_
8-17	1875-1881	ranges	object[98]|abstract[101]	new[98]|new[101]	_	_
8-18	1882-1884	of	object[98]|abstract[101]	new[98]|new[101]	_	_
8-19	1885-1890	their	object[98]|abstract[101]|object|abstract[103]	new[98]|new[101]|giv|new[103]	coref	13-19[187_103]
8-20	1891-1900	detection	object[98]|abstract[101]|abstract[103]	new[98]|new[101]|new[103]	_	_
8-21	1901-1904	and	object[98]	new[98]	_	_
8-22	1905-1911	higher	object[98]|abstract[105]	new[98]|new[105]	_	_
8-23	1912-1919	storage	object[98]|place|abstract[105]	new[98]|new|new[105]	_	_
8-24	1920-1931	stabilities	object[98]|abstract[105]	new[98]|new[105]	_	_
8-25	1932-1936	than	object[98]|abstract[105]	new[98]|new[105]	_	_
8-26	1937-1947	unmodified	object[98]|abstract[105]|substance[107]	new[98]|new[105]|new[107]	coref	20-4[276_107]
8-27	1948-1955	control	object[98]|abstract[105]|abstract|substance[107]	new[98]|new[105]|new|new[107]	_	_
8-28	1956-1966	electrodes	object[98]|abstract[105]|substance[107]	new[98]|new[105]|new[107]	_	_
8-29	1967-1968	.	_	_	_	_

#Text=Moreover , the advantage of the “ green ” approach is the rapid growth of the yeast cells with a high-yield of pure gNPs surrounded by organic compounds that provides the anti-aggregative effect on metallic gNPs , which can be useful as carriers of enzymes and cells in biosensors and biofuel cells .
9-1	1969-1977	Moreover	_	_	_	_
9-2	1978-1979	,	_	_	_	_
9-3	1980-1983	the	event[108]	new[108]	coref	9-12[110_108]
9-4	1984-1993	advantage	event[108]	new[108]	_	_
9-5	1994-1996	of	event[108]	new[108]	_	_
9-6	1997-2000	the	event[108]|abstract[109]	new[108]|new[109]	_	_
9-7	2001-2002	“	event[108]|abstract[109]	new[108]|new[109]	_	_
9-8	2003-2008	green	event[108]|abstract[109]	new[108]|new[109]	_	_
9-9	2009-2010	”	event[108]|abstract[109]	new[108]|new[109]	_	_
9-10	2011-2019	approach	event[108]|abstract[109]	new[108]|new[109]	_	_
9-11	2020-2022	is	_	_	_	_
9-12	2023-2026	the	event[110]	giv[110]	_	_
9-13	2027-2032	rapid	event[110]	giv[110]	_	_
9-14	2033-2039	growth	event[110]	giv[110]	_	_
9-15	2040-2042	of	event[110]	giv[110]	_	_
9-16	2043-2046	the	event[110]|object[112]	giv[110]|new[112]	coref	9-47[0_112]
9-17	2047-2052	yeast	event[110]|substance|object[112]	giv[110]|new|new[112]	_	_
9-18	2053-2058	cells	event[110]|object[112]	giv[110]|new[112]	_	_
9-19	2059-2063	with	event[110]|object[112]	giv[110]|new[112]	_	_
9-20	2064-2065	a	event[110]|object[112]	giv[110]|new[112]	_	_
9-21	2066-2076	high-yield	event[110]|object[112]	giv[110]|new[112]	_	_
9-22	2077-2079	of	event[110]|object[112]	giv[110]|new[112]	_	_
9-23	2080-2084	pure	event[110]|object[112]|abstract[113]	giv[110]|new[112]|giv[113]	coref	9-35[116_113]
9-24	2085-2089	gNPs	event[110]|object[112]|abstract[113]	giv[110]|new[112]|giv[113]	_	_
9-25	2090-2100	surrounded	event[110]|object[112]|abstract[113]	giv[110]|new[112]|giv[113]	_	_
9-26	2101-2103	by	event[110]|object[112]|abstract[113]	giv[110]|new[112]|giv[113]	_	_
9-27	2104-2111	organic	event[110]|object[112]|abstract[113]|substance[114]	giv[110]|new[112]|giv[113]|new[114]	_	_
9-28	2112-2121	compounds	event[110]|object[112]|abstract[113]|substance[114]	giv[110]|new[112]|giv[113]|new[114]	_	_
9-29	2122-2126	that	event[110]|object[112]|abstract[113]|substance[114]	giv[110]|new[112]|giv[113]|new[114]	_	_
9-30	2127-2135	provides	event[110]|object[112]|abstract[113]|substance[114]	giv[110]|new[112]|giv[113]|new[114]	_	_
9-31	2136-2139	the	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]	giv[110]|new[112]|giv[113]|new[114]|new[115]	_	_
9-32	2140-2156	anti-aggregative	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]	giv[110]|new[112]|giv[113]|new[114]|new[115]	_	_
9-33	2157-2163	effect	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]	giv[110]|new[112]|giv[113]|new[114]|new[115]	_	_
9-34	2164-2166	on	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]	giv[110]|new[112]|giv[113]|new[114]|new[115]	_	_
9-35	2167-2175	metallic	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]	_	_
9-36	2176-2180	gNPs	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]	_	_
9-37	2181-2182	,	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]	_	_
9-38	2183-2188	which	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]	_	_
9-39	2189-2192	can	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]	_	_
9-40	2193-2195	be	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]	_	_
9-41	2196-2202	useful	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]	_	_
9-42	2203-2205	as	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]	_	_
9-43	2206-2214	carriers	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]|organization[117]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]|giv[117]	_	_
9-44	2215-2217	of	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]|organization[117]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]|giv[117]	_	_
9-45	2218-2225	enzymes	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]|organization[117]|substance	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]|giv[117]|new	_	_
9-46	2226-2229	and	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]|organization[117]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]|giv[117]	_	_
9-47	2230-2235	cells	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]|organization[117]|object	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]|giv[117]|giv	coref	9-51[123_0]
9-48	2236-2238	in	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]|organization[117]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]|giv[117]	_	_
9-49	2239-2249	biosensors	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]|organization[117]|abstract|abstract[121]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]|giv[117]|giv|giv[121]	coref|coref	9-49[121_0]|19-25[261_121]
9-50	2250-2253	and	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]|organization[117]|abstract[121]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]|giv[117]|giv[121]	_	_
9-51	2254-2261	biofuel	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]|organization[117]|abstract[121]|substance|object[123]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]|giv[117]|giv[121]|new|giv[123]	coref	21-17[288_123]
9-52	2262-2267	cells	event[110]|object[112]|abstract[113]|substance[114]|abstract[115]|abstract[116]|organization[117]|abstract[121]|object[123]	giv[110]|new[112]|giv[113]|new[114]|new[115]|giv[116]|giv[117]|giv[121]|giv[123]	_	_
9-53	2268-2269	.	_	_	_	_

#Text=In the article on The Characterisation and Quantification of Immobilised Concanavalin A on Quartz Surfaces Based on The Competitive Binding to Glucose and Fluorescent Labelled Dextran authored by T. Bich Hoang and coworkers , a simple protocol for the immobilization of Concanavalin A ( Con A ) on a quartz substrate , a common material for gravimetric microsensors , was developed .
10-1	2270-2272	In	_	_	_	_
10-2	2273-2276	the	abstract[124]	new[124]	_	_
10-3	2277-2284	article	abstract[124]	new[124]	_	_
10-4	2285-2287	on	abstract[124]	new[124]	_	_
10-5	2288-2291	The	abstract[124]|abstract[125]	new[124]|new[125]	_	_
10-6	2292-2308	Characterisation	abstract[124]|abstract[125]	new[124]|new[125]	_	_
10-7	2309-2312	and	abstract[124]	new[124]	_	_
10-8	2313-2327	Quantification	abstract[124]|abstract[126]	new[124]|new[126]	_	_
10-9	2328-2330	of	abstract[124]|abstract[126]	new[124]|new[126]	_	_
10-10	2331-2342	Immobilised	abstract[124]|abstract[126]|place[128]	new[124]|new[126]|new[128]	_	_
10-11	2343-2355	Concanavalin	abstract[124]|abstract[126]|substance|place[128]	new[124]|new[126]|new|new[128]	coref	10-42[138_0]
10-12	2356-2357	A	abstract[124]|abstract[126]|place[128]	new[124]|new[126]|new[128]	_	_
10-13	2358-2360	on	abstract[124]|abstract[126]	new[124]|new[126]	_	_
10-14	2361-2367	Quartz	abstract[124]|abstract[126]|abstract|place[130]	new[124]|new[126]|new|new[130]	coref	10-50
10-15	2368-2376	Surfaces	abstract[124]|abstract[126]|place[130]	new[124]|new[126]|new[130]	_	_
10-16	2377-2382	Based	abstract[124]	new[124]	_	_
10-17	2383-2385	on	abstract[124]	new[124]	_	_
10-18	2386-2389	The	abstract[124]|object[131]	new[124]|new[131]	coref	11-2[0_131]
10-19	2390-2401	Competitive	abstract[124]|object[131]	new[124]|new[131]	_	_
10-20	2402-2409	Binding	abstract[124]|object[131]	new[124]|new[131]	_	_
10-21	2410-2412	to	abstract[124]|object[131]	new[124]|new[131]	_	_
10-22	2413-2420	Glucose	abstract[124]|object[131]|substance	new[124]|new[131]|new	coref	11-46
10-23	2421-2424	and	abstract[124]|object[131]	new[124]|new[131]	_	_
10-24	2425-2436	Fluorescent	abstract[124]|object[131]|substance[133]	new[124]|new[131]|new[133]	coref	11-16[148_133]
10-25	2437-2445	Labelled	abstract[124]|object[131]|substance[133]	new[124]|new[131]|new[133]	_	_
10-26	2446-2453	Dextran	abstract[124]|object[131]|substance[133]	new[124]|new[131]|new[133]	_	_
10-27	2454-2462	authored	abstract[124]|object[131]	new[124]|new[131]	_	_
10-28	2463-2465	by	abstract[124]|object[131]	new[124]|new[131]	_	_
10-29	2466-2468	T.	abstract[124]|object[131]|person[134]	new[124]|new[131]|new[134]	_	_
10-30	2469-2473	Bich	abstract[124]|object[131]|person[134]	new[124]|new[131]|new[134]	_	_
10-31	2474-2479	Hoang	abstract[124]|object[131]|person[134]	new[124]|new[131]|new[134]	_	_
10-32	2480-2483	and	abstract[124]|object[131]	new[124]|new[131]	_	_
10-33	2484-2493	coworkers	abstract[124]|object[131]|person	new[124]|new[131]|giv	coref	13-4[180_0]
10-34	2494-2495	,	_	_	_	_
10-35	2496-2497	a	abstract[136]	new[136]	_	_
10-36	2498-2504	simple	abstract[136]	new[136]	_	_
10-37	2505-2513	protocol	abstract[136]	new[136]	_	_
10-38	2514-2517	for	abstract[136]	new[136]	_	_
10-39	2518-2521	the	abstract[136]|abstract[137]	new[136]|new[137]	_	_
10-40	2522-2536	immobilization	abstract[136]|abstract[137]	new[136]|new[137]	_	_
10-41	2537-2539	of	abstract[136]|abstract[137]	new[136]|new[137]	_	_
10-42	2540-2552	Concanavalin	abstract[136]|abstract[137]|substance[138]	new[136]|new[137]|giv[138]	_	_
10-43	2553-2554	A	abstract[136]|abstract[137]|substance[138]	new[136]|new[137]|giv[138]	_	_
10-44	2555-2556	(	abstract[136]|abstract[137]	new[136]|new[137]	_	_
10-45	2557-2560	Con	abstract[136]|abstract[137]|abstract[139]	new[136]|new[137]|new[139]	coref	11-5[146_139]
10-46	2561-2562	A	abstract[136]|abstract[137]|abstract[139]	new[136]|new[137]|new[139]	_	_
10-47	2563-2564	)	abstract[136]|abstract[137]	new[136]|new[137]	_	_
10-48	2565-2567	on	abstract[136]|abstract[137]	new[136]|new[137]	_	_
10-49	2568-2569	a	abstract[136]|abstract[137]|object[141]	new[136]|new[137]|new[141]	coref	20-4[0_141]
10-50	2570-2576	quartz	abstract[136]|abstract[137]|abstract|object[141]	new[136]|new[137]|giv|new[141]	_	_
10-51	2577-2586	substrate	abstract[136]|abstract[137]|object[141]	new[136]|new[137]|new[141]	_	_
10-52	2587-2588	,	_	_	_	_
10-53	2589-2590	a	substance[142]	new[142]	_	_
10-54	2591-2597	common	substance[142]	new[142]	_	_
10-55	2598-2606	material	substance[142]	new[142]	_	_
10-56	2607-2610	for	substance[142]	new[142]	_	_
10-57	2611-2622	gravimetric	substance[142]|object[143]	new[142]|new[143]	_	_
10-58	2623-2635	microsensors	substance[142]|object[143]	new[142]|new[143]	_	_
10-59	2636-2637	,	_	_	_	_
10-60	2638-2641	was	_	_	_	_
10-61	2642-2651	developed	_	_	_	_
10-62	2652-2653	.	_	_	_	_

#Text=The binding activity of the immobilized Con A was assessed by measuring the intensity from fluorescent labelled dextran ( FITC and Alexa 488 ; with a surface coverage ranging from 1.8 × 1011 to 2.1 × 1012 immobilized fluorescent molecules per cm2 ) over a glucose concentration range from 0 to 40 mM , whereas any structural changes to the surface topography were investigated using AFM .
11-1	2654-2657	The	abstract[145]	new[145]	coref	16-1[226_145]
11-2	2658-2665	binding	object|abstract[145]	giv|new[145]	_	_
11-3	2666-2674	activity	abstract[145]	new[145]	_	_
11-4	2675-2677	of	abstract[145]	new[145]	_	_
11-5	2678-2681	the	abstract[145]|abstract[146]	new[145]|giv[146]	_	_
11-6	2682-2693	immobilized	abstract[145]|abstract[146]	new[145]|giv[146]	_	_
11-7	2694-2697	Con	abstract[145]|abstract[146]	new[145]|giv[146]	_	_
11-8	2698-2699	A	abstract[145]|abstract[146]	new[145]|giv[146]	_	_
11-9	2700-2703	was	_	_	_	_
11-10	2704-2712	assessed	_	_	_	_
11-11	2713-2715	by	_	_	_	_
11-12	2716-2725	measuring	_	_	_	_
11-13	2726-2729	the	abstract[147]	new[147]	coref	12-9[168_147]
11-14	2730-2739	intensity	abstract[147]	new[147]	_	_
11-15	2740-2744	from	abstract[147]	new[147]	_	_
11-16	2745-2756	fluorescent	abstract[147]|substance[148]	new[147]|giv[148]	appos	11-20[150_148]
11-17	2757-2765	labelled	abstract[147]|substance[148]	new[147]|giv[148]	_	_
11-18	2766-2773	dextran	abstract[147]|substance[148]	new[147]|giv[148]	_	_
11-19	2774-2775	(	abstract[147]	new[147]	_	_
11-20	2776-2780	FITC	abstract[147]|abstract|substance[150]	new[147]|new|giv[150]	_	_
11-21	2781-2784	and	abstract[147]|substance[150]	new[147]|giv[150]	_	_
11-22	2785-2790	Alexa	abstract[147]|substance[150]|organization[151]	new[147]|giv[150]|new[151]	_	_
11-23	2791-2794	488	abstract[147]|substance[150]|organization[151]	new[147]|giv[150]|new[151]	_	_
11-24	2795-2796	;	abstract[147]	new[147]	_	_
11-25	2797-2801	with	abstract[147]	new[147]	_	_
11-26	2802-2803	a	abstract[147]|abstract[153]	new[147]|new[153]	_	_
11-27	2804-2811	surface	abstract[147]|place|abstract[153]	new[147]|giv|new[153]	coref	11-61
11-28	2812-2820	coverage	abstract[147]|abstract[153]	new[147]|new[153]	_	_
11-29	2821-2828	ranging	abstract[147]|abstract[153]	new[147]|new[153]	_	_
11-30	2829-2833	from	abstract[147]|abstract[153]	new[147]|new[153]	_	_
11-31	2834-2837	1.8	abstract[147]|abstract[153]|object[154]	new[147]|new[153]|new[154]	coref	19-40[265_154]
11-32	2838-2839	×	abstract[147]|abstract[153]|object[154]	new[147]|new[153]|new[154]	_	_
11-33	2840-2844	1011	abstract[147]|abstract[153]|object[154]	new[147]|new[153]|new[154]	_	_
11-34	2845-2847	to	abstract[147]|abstract[153]|object[154]	new[147]|new[153]|new[154]	_	_
11-35	2848-2851	2.1	abstract[147]|abstract[153]|object[154]	new[147]|new[153]|new[154]	_	_
11-36	2852-2853	×	abstract[147]|abstract[153]|object[154]	new[147]|new[153]|new[154]	_	_
11-37	2854-2858	1012	abstract[147]|abstract[153]|object[154]	new[147]|new[153]|new[154]	_	_
11-38	2859-2870	immobilized	abstract[147]|abstract[153]|object[154]	new[147]|new[153]|new[154]	_	_
11-39	2871-2882	fluorescent	abstract[147]|abstract[153]|object[154]	new[147]|new[153]|new[154]	_	_
11-40	2883-2892	molecules	abstract[147]|abstract[153]|object[154]	new[147]|new[153]|new[154]	_	_
11-41	2893-2896	per	abstract[147]|abstract[153]|object[154]	new[147]|new[153]|new[154]	_	_
11-42	2897-2900	cm2	abstract[147]|abstract[153]|object[154]|abstract	new[147]|new[153]|new[154]|new	_	_
11-43	2901-2902	)	abstract[147]	new[147]	_	_
11-44	2903-2907	over	_	_	_	_
11-45	2908-2909	a	abstract[158]	giv[158]	coref	17-12[238_158]
11-46	2910-2917	glucose	substance|abstract[158]	giv|giv[158]	_	_
11-47	2918-2931	concentration	abstract|abstract[158]	new|giv[158]	_	_
11-48	2932-2937	range	abstract[158]	giv[158]	_	_
11-49	2938-2942	from	abstract[158]	giv[158]	_	_
11-50	2943-2944	0	abstract[158]|abstract	giv[158]|new	_	_
11-51	2945-2947	to	abstract[158]	giv[158]	_	_
11-52	2948-2950	40	abstract[158]|abstract[160]	giv[158]|new[160]	_	_
11-53	2951-2953	mM	abstract[158]|abstract[160]	giv[158]|new[160]	_	_
11-54	2954-2955	,	_	_	_	_
11-55	2956-2963	whereas	_	_	_	_
11-56	2964-2967	any	abstract[161]	new[161]	_	_
11-57	2968-2978	structural	abstract[161]	new[161]	_	_
11-58	2979-2986	changes	abstract[161]	new[161]	_	_
11-59	2987-2989	to	abstract[161]	new[161]	_	_
11-60	2990-2993	the	abstract[161]|abstract[163]	new[161]|new[163]	_	_
11-61	2994-3001	surface	abstract[161]|place|abstract[163]	new[161]|giv|new[163]	coref	12-20
11-62	3002-3012	topography	abstract[161]|abstract[163]	new[161]|new[163]	_	_
11-63	3013-3017	were	_	_	_	_
11-64	3018-3030	investigated	_	_	_	_
11-65	3031-3036	using	_	_	_	_
11-66	3037-3040	AFM	abstract	giv	_	_
11-67	3041-3042	.	_	_	_	_

#Text=These complementing measurements verified that a change in the fluorescence intensity was accompanied with a change in the average surface roughness , and thereby the composition ( addition and loss of dextran ) at the sample surface .
12-1	3043-3048	These	abstract[165]	new[165]	coref	18-16[248_165]
12-2	3049-3062	complementing	abstract[165]	new[165]	_	_
12-3	3063-3075	measurements	abstract[165]	new[165]	_	_
12-4	3076-3084	verified	_	_	_	_
12-5	3085-3089	that	_	_	_	_
12-6	3090-3091	a	event[166]	new[166]	_	_
12-7	3092-3098	change	event[166]	new[166]	_	_
12-8	3099-3101	in	event[166]	new[166]	_	_
12-9	3102-3105	the	event[166]|abstract[168]	new[166]|giv[168]	_	_
12-10	3106-3118	fluorescence	event[166]|abstract|abstract[168]	new[166]|new|giv[168]	_	_
12-11	3119-3128	intensity	event[166]|abstract[168]	new[166]|giv[168]	_	_
12-12	3129-3132	was	_	_	_	_
12-13	3133-3144	accompanied	_	_	_	_
12-14	3145-3149	with	_	_	_	_
12-15	3150-3151	a	event[169]	new[169]	coref	16-20[233_169]
12-16	3152-3158	change	event[169]	new[169]	_	_
12-17	3159-3161	in	event[169]	new[169]	_	_
12-18	3162-3165	the	event[169]|abstract[171]	new[169]|new[171]	_	_
12-19	3166-3173	average	event[169]|abstract[171]	new[169]|new[171]	_	_
12-20	3174-3181	surface	event[169]|place|abstract[171]	new[169]|giv|new[171]	coref	12-35[178_0]
12-21	3182-3191	roughness	event[169]|abstract[171]	new[169]|new[171]	_	_
12-22	3192-3193	,	event[169]	new[169]	_	_
12-23	3194-3197	and	event[169]	new[169]	_	_
12-24	3198-3205	thereby	event[169]|abstract[172]	new[169]|giv[172]	appos	12-28[0_172]
12-25	3206-3209	the	event[169]|abstract[172]	new[169]|giv[172]	_	_
12-26	3210-3221	composition	event[169]|abstract[172]	new[169]|giv[172]	_	_
12-27	3222-3223	(	_	_	_	_
12-28	3224-3232	addition	abstract|abstract[174]	giv|giv[174]	appos|appos	12-28[174_0]|12-30[175_174]
12-29	3233-3236	and	abstract[174]	giv[174]	_	_
12-30	3237-3241	loss	abstract[174]|abstract[175]	giv[174]|giv[175]	_	_
12-31	3242-3244	of	abstract[174]|abstract[175]	giv[174]|giv[175]	_	_
12-32	3245-3252	dextran	abstract[174]|abstract[175]|substance	giv[174]|giv[175]|new	_	_
12-33	3253-3254	)	_	_	_	_
12-34	3255-3257	at	_	_	_	_
12-35	3258-3261	the	place[178]	giv[178]	_	_
12-36	3262-3268	sample	object|place[178]	new|giv[178]	_	_
12-37	3269-3276	surface	place[178]	giv[178]	_	_
12-38	3277-3278	.	_	_	_	_

#Text=H. Aldewachi and coworkers in their paper on the Study of the Stability of Functionalized Gold Nanoparticles for the Colorimetric Detection of Dipeptidyl Peptidase IV
13-1	3279-3281	H.	person[179]	new[179]	_	_
13-2	3282-3291	Aldewachi	person[179]	new[179]	_	_
13-3	3292-3295	and	_	_	_	_
13-4	3296-3305	coworkers	person[180]	giv[180]	ana	13-6[0_180]
13-5	3306-3308	in	person[180]	giv[180]	_	_
13-6	3309-3314	their	person[180]|person|abstract[182]	giv[180]|giv|giv[182]	_	_
13-7	3315-3320	paper	person[180]|abstract[182]	giv[180]|giv[182]	_	_
13-8	3321-3323	on	person[180]|abstract[182]	giv[180]|giv[182]	_	_
13-9	3324-3327	the	person[180]|abstract[182]|abstract[183]	giv[180]|giv[182]|new[183]	_	_
13-10	3328-3333	Study	person[180]|abstract[182]|abstract[183]	giv[180]|giv[182]|new[183]	_	_
13-11	3334-3336	of	person[180]|abstract[182]|abstract[183]	giv[180]|giv[182]|new[183]	_	_
13-12	3337-3340	the	person[180]|abstract[182]|abstract[183]|abstract[184]	giv[180]|giv[182]|new[183]|new[184]	coref	15-38[220_184]
13-13	3341-3350	Stability	person[180]|abstract[182]|abstract[183]|abstract[184]	giv[180]|giv[182]|new[183]|new[184]	_	_
13-14	3351-3353	of	person[180]|abstract[182]|abstract[183]|abstract[184]	giv[180]|giv[182]|new[183]|new[184]	_	_
13-15	3354-3368	Functionalized	person[180]|abstract[182]|abstract[183]|abstract[184]|abstract[186]	giv[180]|giv[182]|new[183]|new[184]|giv[186]	_	_
13-16	3369-3373	Gold	person[180]|abstract[182]|abstract[183]|abstract[184]|person|abstract[186]	giv[180]|giv[182]|new[183]|new[184]|new|giv[186]	_	_
13-17	3374-3387	Nanoparticles	person[180]|abstract[182]|abstract[183]|abstract[184]|abstract[186]	giv[180]|giv[182]|new[183]|new[184]|giv[186]	_	_
13-18	3388-3391	for	person[180]|abstract[182]|abstract[183]|abstract[184]|abstract[186]	giv[180]|giv[182]|new[183]|new[184]|giv[186]	_	_
13-19	3392-3395	the	person[180]|abstract[182]|abstract[183]|abstract[184]|abstract[186]|abstract[187]	giv[180]|giv[182]|new[183]|new[184]|giv[186]|giv[187]	coref	14-14[197_187]
13-20	3396-3408	Colorimetric	person[180]|abstract[182]|abstract[183]|abstract[184]|abstract[186]|abstract[187]	giv[180]|giv[182]|new[183]|new[184]|giv[186]|giv[187]	_	_
13-21	3409-3418	Detection	person[180]|abstract[182]|abstract[183]|abstract[184]|abstract[186]|abstract[187]	giv[180]|giv[182]|new[183]|new[184]|giv[186]|giv[187]	_	_
13-22	3419-3421	of	person[180]|abstract[182]|abstract[183]|abstract[184]|abstract[186]|abstract[187]	giv[180]|giv[182]|new[183]|new[184]|giv[186]|giv[187]	_	_
13-23	3422-3432	Dipeptidyl	person[180]|abstract[182]|abstract[183]|abstract[184]|abstract[186]|abstract[187]|abstract|abstract[189]	giv[180]|giv[182]|new[183]|new[184]|giv[186]|giv[187]|new|new[189]	coref|coref	14-18|14-18[199_189]
13-24	3433-3442	Peptidase	person[180]|abstract[182]|abstract[183]|abstract[184]|abstract[186]|abstract[187]|abstract[189]	giv[180]|giv[182]|new[183]|new[184]|giv[186]|giv[187]|new[189]	_	_
13-25	3443-3445	IV	person[180]|abstract[182]|abstract[183]|abstract[184]|abstract[186]|abstract[187]|person	giv[180]|giv[182]|new[183]|new[184]|giv[186]|giv[187]|new	_	_

#Text=report on three stabilization strategies of gold nanoparticles and their practical applications for the visual detection of dipeptidyl peptidase IV ( DPP-IV ) , an enzyme of high clinical importance , especially as a diagnostic and prognostic marker of various inflammatory disorders and tumors .
14-1	3446-3452	report	_	_	_	_
14-2	3453-3455	on	_	_	_	_
14-3	3456-3461	three	abstract[192]	new[192]	_	_
14-4	3462-3475	stabilization	abstract|abstract[192]	new|new[192]	_	_
14-5	3476-3486	strategies	abstract[192]	new[192]	_	_
14-6	3487-3489	of	abstract[192]	new[192]	_	_
14-7	3490-3494	gold	abstract[192]|substance|object[194]	new[192]|new|giv[194]	ana	14-10[0_194]
14-8	3495-3508	nanoparticles	abstract[192]|object[194]	new[192]|giv[194]	_	_
14-9	3509-3512	and	_	_	_	_
14-10	3513-3518	their	object|abstract[196]	giv|giv[196]	_	_
14-11	3519-3528	practical	abstract[196]	giv[196]	_	_
14-12	3529-3541	applications	abstract[196]	giv[196]	_	_
14-13	3542-3545	for	abstract[196]	giv[196]	_	_
14-14	3546-3549	the	abstract[196]|abstract[197]	giv[196]|giv[197]	_	_
14-15	3550-3556	visual	abstract[196]|abstract[197]	giv[196]|giv[197]	_	_
14-16	3557-3566	detection	abstract[196]|abstract[197]	giv[196]|giv[197]	_	_
14-17	3567-3569	of	abstract[196]|abstract[197]	giv[196]|giv[197]	_	_
14-18	3570-3580	dipeptidyl	abstract[196]|abstract[197]|abstract|abstract[199]	giv[196]|giv[197]|giv|giv[199]	appos	14-22[0_199]
14-19	3581-3590	peptidase	abstract[196]|abstract[197]|abstract[199]	giv[196]|giv[197]|giv[199]	_	_
14-20	3591-3593	IV	abstract[196]|abstract[197]|abstract[199]	giv[196]|giv[197]|giv[199]	_	_
14-21	3594-3595	(	_	_	_	_
14-22	3596-3602	DPP-IV	abstract	giv	coref	18-25
14-23	3603-3604	)	_	_	_	_
14-24	3605-3606	,	_	_	_	_
14-25	3607-3609	an	substance[201]	new[201]	_	_
14-26	3610-3616	enzyme	substance[201]	new[201]	_	_
14-27	3617-3619	of	substance[201]	new[201]	_	_
14-28	3620-3624	high	substance[201]|abstract[202]	new[201]|new[202]	_	_
14-29	3625-3633	clinical	substance[201]|abstract[202]	new[201]|new[202]	_	_
14-30	3634-3644	importance	substance[201]|abstract[202]	new[201]|new[202]	_	_
14-31	3645-3646	,	substance[201]	new[201]	_	_
14-32	3647-3657	especially	substance[201]|abstract[203]	new[201]|giv[203]	_	_
14-33	3658-3660	as	substance[201]|abstract[203]	new[201]|giv[203]	_	_
14-34	3661-3662	a	substance[201]|abstract[203]	new[201]|giv[203]	_	_
14-35	3663-3673	diagnostic	substance[201]|abstract[203]	new[201]|giv[203]	_	_
14-36	3674-3677	and	substance[201]|abstract[203]	new[201]|giv[203]	_	_
14-37	3678-3688	prognostic	substance[201]|abstract[203]	new[201]|giv[203]	_	_
14-38	3689-3695	marker	substance[201]|abstract[203]	new[201]|giv[203]	_	_
14-39	3696-3698	of	substance[201]|abstract[203]	new[201]|giv[203]	_	_
14-40	3699-3706	various	substance[201]|abstract[203]|abstract[204]	new[201]|giv[203]|new[204]	_	_
14-41	3707-3719	inflammatory	substance[201]|abstract[203]|abstract[204]	new[201]|giv[203]|new[204]	_	_
14-42	3720-3729	disorders	substance[201]|abstract[203]|abstract[204]	new[201]|giv[203]|new[204]	_	_
14-43	3730-3733	and	substance[201]|abstract[203]	new[201]|giv[203]	_	_
14-44	3734-3740	tumors	substance[201]|abstract[203]|abstract	new[201]|giv[203]|new	_	_
14-45	3741-3742	.	_	_	_	_

#Text=The first strategy used the incorporation of a PEGylated sequence with a dithiol anchor to create biorecognition ligands ; the other two strategies used a peptide sequence ( CALNN ) selected from 58 peptide sequences tested for their high stability and resistance to electrolyte-induced Au NP aggregation .
15-1	3743-3746	The	abstract[206]	new[206]	_	_
15-2	3747-3752	first	abstract[206]	new[206]	_	_
15-3	3753-3761	strategy	abstract[206]	new[206]	_	_
15-4	3762-3766	used	_	_	_	_
15-5	3767-3770	the	event[207]	new[207]	_	_
15-6	3771-3784	incorporation	event[207]	new[207]	_	_
15-7	3785-3787	of	event[207]	new[207]	_	_
15-8	3788-3789	a	event[207]|abstract[208]	new[207]|new[208]	coref	15-25[215_208]
15-9	3790-3799	PEGylated	event[207]|abstract[208]	new[207]|new[208]	_	_
15-10	3800-3808	sequence	event[207]|abstract[208]	new[207]|new[208]	_	_
15-11	3809-3813	with	event[207]|abstract[208]	new[207]|new[208]	_	_
15-12	3814-3815	a	event[207]|abstract[208]|object[210]	new[207]|new[208]|new[210]	_	_
15-13	3816-3823	dithiol	event[207]|abstract[208]|abstract|object[210]	new[207]|new[208]|new|new[210]	_	_
15-14	3824-3830	anchor	event[207]|abstract[208]|object[210]	new[207]|new[208]|new[210]	_	_
15-15	3831-3833	to	_	_	_	_
15-16	3834-3840	create	_	_	_	_
15-17	3841-3855	biorecognition	abstract|substance[212]	new|new[212]	_	_
15-18	3856-3863	ligands	substance[212]	new[212]	_	_
15-19	3864-3865	;	_	_	_	_
15-20	3866-3869	the	abstract[213]	new[213]	_	_
15-21	3870-3875	other	abstract[213]	new[213]	_	_
15-22	3876-3879	two	abstract[213]	new[213]	_	_
15-23	3880-3890	strategies	abstract[213]	new[213]	_	_
15-24	3891-3895	used	_	_	_	_
15-25	3896-3897	a	abstract[215]	giv[215]	appos	15-29[0_215]
15-26	3898-3905	peptide	abstract|abstract[215]	giv|giv[215]	coref	15-34
15-27	3906-3914	sequence	abstract[215]	giv[215]	_	_
15-28	3915-3916	(	_	_	_	_
15-29	3917-3922	CALNN	abstract	giv	_	_
15-30	3923-3924	)	_	_	_	_
15-31	3925-3933	selected	_	_	_	_
15-32	3934-3938	from	_	_	_	_
15-33	3939-3941	58	abstract[218]	new[218]	ana	15-38[0_218]
15-34	3942-3949	peptide	abstract|abstract[218]	giv|new[218]	_	_
15-35	3950-3959	sequences	abstract[218]	new[218]	_	_
15-36	3960-3966	tested	abstract[218]	new[218]	_	_
15-37	3967-3970	for	abstract[218]	new[218]	_	_
15-38	3971-3976	their	abstract[218]|abstract|abstract[220]	new[218]|giv|giv[220]	coref	17-22[240_220]
15-39	3977-3981	high	abstract[218]|abstract[220]	new[218]|giv[220]	_	_
15-40	3982-3991	stability	abstract[218]|abstract[220]	new[218]|giv[220]	_	_
15-41	3992-3995	and	abstract[218]	new[218]	_	_
15-42	3996-4006	resistance	abstract[218]|abstract[221]	new[218]|new[221]	_	_
15-43	4007-4009	to	abstract[218]|abstract[221]	new[218]|new[221]	_	_
15-44	4010-4029	electrolyte-induced	abstract[218]|abstract[221]|abstract[224]	new[218]|new[221]|new[224]	_	_
15-45	4030-4032	Au	abstract[218]|abstract[221]|person|organization[223]|abstract[224]	new[218]|new[221]|new|new[223]|new[224]	_	_
15-46	4033-4035	NP	abstract[218]|abstract[221]|organization[223]|abstract[224]	new[218]|new[221]|new[223]|new[224]	_	_
15-47	4036-4047	aggregation	abstract[218]|abstract[221]|abstract[224]	new[218]|new[221]|new[224]	_	_
15-48	4048-4049	.	_	_	_	_

#Text=DPP-IV/CD26 activity using the three approaches was detected under optimal conditions and only C/G-capped AuNPs showed a response with a color change when incubated with DPP-IV/CD26 .
16-1	4050-4061	DPP-IV/CD26	abstract|abstract[226]	new|giv[226]	coref|coref	16-26|18-25[251_226]
16-2	4062-4070	activity	abstract[226]	giv[226]	_	_
16-3	4071-4076	using	abstract[226]	giv[226]	_	_
16-4	4077-4080	the	abstract[226]|abstract[227]	giv[226]|new[227]	_	_
16-5	4081-4086	three	abstract[226]|abstract[227]	giv[226]|new[227]	_	_
16-6	4087-4097	approaches	abstract[226]|abstract[227]	giv[226]|new[227]	_	_
16-7	4098-4101	was	_	_	_	_
16-8	4102-4110	detected	_	_	_	_
16-9	4111-4116	under	_	_	_	_
16-10	4117-4124	optimal	abstract[228]	new[228]	coref	20-7[279_228]
16-11	4125-4135	conditions	abstract[228]	new[228]	_	_
16-12	4136-4139	and	_	_	_	_
16-13	4140-4144	only	abstract[230]	new[230]	_	_
16-14	4145-4155	C/G-capped	animal|abstract[230]	new|new[230]	coref	17-1
16-15	4156-4161	AuNPs	abstract[230]	new[230]	_	_
16-16	4162-4168	showed	_	_	_	_
16-17	4169-4170	a	event[231]	new[231]	_	_
16-18	4171-4179	response	event[231]	new[231]	_	_
16-19	4180-4184	with	event[231]	new[231]	_	_
16-20	4185-4186	a	event[231]|event[233]	new[231]|giv[233]	_	_
16-21	4187-4192	color	event[231]|abstract|event[233]	new[231]|new|giv[233]	_	_
16-22	4193-4199	change	event[231]|event[233]	new[231]|giv[233]	_	_
16-23	4200-4204	when	_	_	_	_
16-24	4205-4214	incubated	_	_	_	_
16-25	4215-4219	with	_	_	_	_
16-26	4220-4231	DPP-IV/CD26	abstract	giv	_	_
16-27	4232-4233	.	_	_	_	_

#Text=C/G-capped AuNPs were less sensitive than the monofunctionalized systems , with a dynamic range of 10 – 30 U/L but with very high stability in ionic solutions .
17-1	4234-4244	C/G-capped	animal|object[236]	giv|new[236]	_	_
17-2	4245-4250	AuNPs	object[236]	new[236]	_	_
17-3	4251-4255	were	_	_	_	_
17-4	4256-4260	less	_	_	_	_
17-5	4261-4270	sensitive	_	_	_	_
17-6	4271-4275	than	_	_	_	_
17-7	4276-4279	the	object[237]	giv[237]	_	_
17-8	4280-4298	monofunctionalized	object[237]	giv[237]	_	_
17-9	4299-4306	systems	object[237]	giv[237]	_	_
17-10	4307-4308	,	_	_	_	_
17-11	4309-4313	with	_	_	_	_
17-12	4314-4315	a	abstract[238]	giv[238]	_	_
17-13	4316-4323	dynamic	abstract[238]	giv[238]	_	_
17-14	4324-4329	range	abstract[238]	giv[238]	_	_
17-15	4330-4332	of	abstract[238]	giv[238]	_	_
17-16	4333-4335	10	abstract[238]|abstract[239]	giv[238]|new[239]	_	_
17-17	4336-4337	–	abstract[238]|abstract[239]	giv[238]|new[239]	_	_
17-18	4338-4340	30	abstract[238]|abstract[239]	giv[238]|new[239]	_	_
17-19	4341-4344	U/L	abstract[238]|abstract[239]	giv[238]|new[239]	_	_
17-20	4345-4348	but	_	_	_	_
17-21	4349-4353	with	_	_	_	_
17-22	4354-4358	very	abstract[240]	giv[240]	_	_
17-23	4359-4363	high	abstract[240]	giv[240]	_	_
17-24	4364-4373	stability	abstract[240]	giv[240]	_	_
17-25	4374-4376	in	abstract[240]	giv[240]	_	_
17-26	4377-4382	ionic	abstract[240]|substance[241]	giv[240]|new[241]	_	_
17-27	4383-4392	solutions	abstract[240]|substance[241]	giv[240]|new[241]	_	_
17-28	4393-4394	.	_	_	_	_

#Text=The developed biofunctionalized assay was successfully evaluated by gel electrophoresis , zeta potential , and hydrodynamic radius measurements and tested for the assay of DPP-IV activity .
18-1	4395-4398	The	object[242]	new[242]	coref	18-22[249_242]
18-2	4399-4408	developed	object[242]	new[242]	_	_
18-3	4409-4426	biofunctionalized	object[242]	new[242]	_	_
18-4	4427-4432	assay	object[242]	new[242]	_	_
18-5	4433-4436	was	_	_	_	_
18-6	4437-4449	successfully	_	_	_	_
18-7	4450-4459	evaluated	_	_	_	_
18-8	4460-4462	by	_	_	_	_
18-9	4463-4466	gel	substance|person[244]	new|new[244]	_	_
18-10	4467-4482	electrophoresis	person[244]	new[244]	_	_
18-11	4483-4484	,	_	_	_	_
18-12	4485-4489	zeta	organization|abstract[246]	new|giv[246]	_	_
18-13	4490-4499	potential	abstract[246]	giv[246]	_	_
18-14	4500-4501	,	_	_	_	_
18-15	4502-4505	and	_	_	_	_
18-16	4506-4518	hydrodynamic	abstract[247]|abstract[248]	new[247]|giv[248]	_	_
18-17	4519-4525	radius	abstract[247]|abstract[248]	new[247]|giv[248]	_	_
18-18	4526-4538	measurements	abstract[248]	giv[248]	_	_
18-19	4539-4542	and	_	_	_	_
18-20	4543-4549	tested	_	_	_	_
18-21	4550-4553	for	_	_	_	_
18-22	4554-4557	the	object[249]	giv[249]	_	_
18-23	4558-4563	assay	object[249]	giv[249]	_	_
18-24	4564-4566	of	object[249]	giv[249]	_	_
18-25	4567-4573	DPP-IV	object[249]|abstract|abstract[251]	giv[249]|giv|giv[251]	_	_
18-26	4574-4582	activity	object[249]|abstract[251]	giv[249]|giv[251]	_	_
18-27	4583-4584	.	_	_	_	_

#Text=Finally , in the review : Biosensor Applications of Electrodeposited Nanostructures , the author K.J. Stine traces an overview on the area of developing biosensors based on electrodeposited nanostructures , which has many possible applications to the detection of small molecules , metabolites , protein antigens , oligonucleotides , and other targets , including bacteria and viruses .
19-1	4585-4592	Finally	_	_	_	_
19-2	4593-4594	,	_	_	_	_
19-3	4595-4597	in	_	_	_	_
19-4	4598-4601	the	abstract[252]	new[252]	appos	19-7[254_252]
19-5	4602-4608	review	abstract[252]	new[252]	_	_
19-6	4609-4610	:	_	_	_	_
19-7	4611-4620	Biosensor	place|abstract[254]	giv|giv[254]	coref	19-33[263_254]
19-8	4621-4633	Applications	abstract[254]	giv[254]	_	_
19-9	4634-4636	of	abstract[254]	giv[254]	_	_
19-10	4637-4653	Electrodeposited	abstract[254]|abstract|abstract[256]	giv[254]|new|new[256]	coref	19-28[262_256]
19-11	4654-4668	Nanostructures	abstract[254]|abstract[256]	giv[254]|new[256]	_	_
19-12	4669-4670	,	_	_	_	_
19-13	4671-4674	the	person[257]|organization[258]	new[257]|new[258]	_	_
19-14	4675-4681	author	person[257]|organization[258]	new[257]|new[258]	_	_
19-15	4682-4686	K.J.	organization[258]	new[258]	_	_
19-16	4687-4692	Stine	organization[258]	new[258]	_	_
19-17	4693-4699	traces	_	_	_	_
19-18	4700-4702	an	abstract[259]	new[259]	_	_
19-19	4703-4711	overview	abstract[259]	new[259]	_	_
19-20	4712-4714	on	abstract[259]	new[259]	_	_
19-21	4715-4718	the	abstract[259]|abstract[260]	new[259]|new[260]	_	_
19-22	4719-4723	area	abstract[259]|abstract[260]	new[259]|new[260]	_	_
19-23	4724-4726	of	abstract[259]|abstract[260]	new[259]|new[260]	_	_
19-24	4727-4737	developing	abstract[259]|abstract[260]	new[259]|new[260]	_	_
19-25	4738-4748	biosensors	abstract[259]|abstract[260]|abstract[261]	new[259]|new[260]|giv[261]	_	_
19-26	4749-4754	based	abstract[259]|abstract[260]|abstract[261]	new[259]|new[260]|giv[261]	_	_
19-27	4755-4757	on	abstract[259]|abstract[260]|abstract[261]	new[259]|new[260]|giv[261]	_	_
19-28	4758-4774	electrodeposited	abstract[259]|abstract[260]|abstract[261]|abstract[262]	new[259]|new[260]|giv[261]|giv[262]	_	_
19-29	4775-4789	nanostructures	abstract[259]|abstract[260]|abstract[261]|abstract[262]	new[259]|new[260]|giv[261]|giv[262]	_	_
19-30	4790-4791	,	abstract[259]|abstract[260]|abstract[261]	new[259]|new[260]|giv[261]	_	_
19-31	4792-4797	which	abstract[259]|abstract[260]|abstract[261]	new[259]|new[260]|giv[261]	_	_
19-32	4798-4801	has	abstract[259]|abstract[260]|abstract[261]	new[259]|new[260]|giv[261]	_	_
19-33	4802-4806	many	abstract[259]|abstract[260]|abstract[261]|abstract[263]	new[259]|new[260]|giv[261]|giv[263]	_	_
19-34	4807-4815	possible	abstract[259]|abstract[260]|abstract[261]|abstract[263]	new[259]|new[260]|giv[261]|giv[263]	_	_
19-35	4816-4828	applications	abstract[259]|abstract[260]|abstract[261]|abstract[263]	new[259]|new[260]|giv[261]|giv[263]	_	_
19-36	4829-4831	to	abstract[259]|abstract[260]|abstract[261]|abstract[263]	new[259]|new[260]|giv[261]|giv[263]	_	_
19-37	4832-4835	the	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]	new[259]|new[260]|giv[261]|giv[263]|new[264]	_	_
19-38	4836-4845	detection	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]	new[259]|new[260]|giv[261]|giv[263]|new[264]	_	_
19-39	4846-4848	of	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]	new[259]|new[260]|giv[261]|giv[263]|new[264]	_	_
19-40	4849-4854	small	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[265]|object[266]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[265]|giv[266]	coref	19-40[266_265]
19-41	4855-4864	molecules	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[265]|object[266]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[265]|giv[266]	_	_
19-42	4865-4866	,	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]	_	_
19-43	4867-4878	metabolites	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]|substance	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]|new	_	_
19-44	4879-4880	,	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]	_	_
19-45	4881-4888	protein	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]|substance|substance[269]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]|giv|new[269]	_	_
19-46	4889-4897	antigens	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]|substance[269]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]|new[269]	_	_
19-47	4898-4899	,	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]	_	_
19-48	4900-4916	oligonucleotides	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]|abstract	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]|new	coref	21-21[289_0]
19-49	4917-4918	,	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]	_	_
19-50	4919-4922	and	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]	_	_
19-51	4923-4928	other	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]|abstract[271]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]|new[271]	coref	21-1[282_271]
19-52	4929-4936	targets	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]|abstract[271]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]|new[271]	_	_
19-53	4937-4938	,	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]|abstract[271]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]|new[271]	_	_
19-54	4939-4948	including	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]|abstract[271]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]|new[271]	_	_
19-55	4949-4957	bacteria	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]|abstract[271]|animal	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]|new[271]|new	_	_
19-56	4958-4961	and	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]|abstract[271]	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]|new[271]	_	_
19-57	4962-4969	viruses	abstract[259]|abstract[260]|abstract[261]|abstract[263]|abstract[264]|object[266]|abstract[271]|abstract	new[259]|new[260]|giv[261]|giv[263]|new[264]|giv[266]|new[271]|new	_	_
19-58	4970-4971	.	_	_	_	_

#Text=The variety of substrate electrodes and preparation conditions can produce a vast range of structures .
20-1	4972-4975	The	abstract[274]	new[274]	_	_
20-2	4976-4983	variety	abstract[274]	new[274]	_	_
20-3	4984-4986	of	abstract[274]	new[274]	_	_
20-4	4987-4996	substrate	abstract[274]|object|substance[276]|substance[277]	new[274]|giv|giv[276]|giv[277]	coref	20-4[277_276]
20-5	4997-5007	electrodes	abstract[274]|substance[276]|substance[277]	new[274]|giv[276]|giv[277]	_	_
20-6	5008-5011	and	abstract[274]|substance[277]	new[274]|giv[277]	_	_
20-7	5012-5023	preparation	abstract[274]|substance[277]|abstract|abstract[279]	new[274]|giv[277]|new|giv[279]	_	_
20-8	5024-5034	conditions	abstract[274]|substance[277]|abstract[279]	new[274]|giv[277]|giv[279]	_	_
20-9	5035-5038	can	_	_	_	_
20-10	5039-5046	produce	_	_	_	_
20-11	5047-5048	a	abstract[280]	new[280]	_	_
20-12	5049-5053	vast	abstract[280]	new[280]	_	_
20-13	5054-5059	range	abstract[280]	new[280]	_	_
20-14	5060-5062	of	abstract[280]	new[280]	_	_
20-15	5063-5073	structures	abstract[280]|abstract	new[280]|new	_	_
20-16	5074-5075	.	_	_	_	_

#Text=Many additional targets of high interest for the development of diagnostics , such as glycoproteins , circulating tumor cells , circulating oligonucleotides , microRNAs , and content in microvesicles remain unexplored .
21-1	5076-5080	Many	abstract[282]	giv[282]	_	_
21-2	5081-5091	additional	abstract[282]	giv[282]	_	_
21-3	5092-5099	targets	abstract[282]	giv[282]	_	_
21-4	5100-5102	of	abstract[282]	giv[282]	_	_
21-5	5103-5107	high	abstract[282]|abstract[283]	giv[282]|new[283]	_	_
21-6	5108-5116	interest	abstract[282]|abstract[283]	giv[282]|new[283]	_	_
21-7	5117-5120	for	abstract[282]|abstract[283]	giv[282]|new[283]	_	_
21-8	5121-5124	the	abstract[282]|abstract[283]|event[284]	giv[282]|new[283]|new[284]	_	_
21-9	5125-5136	development	abstract[282]|abstract[283]|event[284]	giv[282]|new[283]|new[284]	_	_
21-10	5137-5139	of	abstract[282]|abstract[283]|event[284]	giv[282]|new[283]|new[284]	_	_
21-11	5140-5151	diagnostics	abstract[282]|abstract[283]|event[284]|abstract	giv[282]|new[283]|new[284]|new	_	_
21-12	5152-5153	,	abstract[282]	giv[282]	_	_
21-13	5154-5158	such	abstract[282]	giv[282]	_	_
21-14	5159-5161	as	abstract[282]	giv[282]	_	_
21-15	5162-5175	glycoproteins	abstract[282]|substance	giv[282]|new	_	_
21-16	5176-5177	,	abstract[282]	giv[282]	_	_
21-17	5178-5189	circulating	abstract[282]|object[288]	giv[282]|giv[288]	_	_
21-18	5190-5195	tumor	abstract[282]|object|object[288]	giv[282]|new|giv[288]	_	_
21-19	5196-5201	cells	abstract[282]|object[288]	giv[282]|giv[288]	_	_
21-20	5202-5203	,	abstract[282]	giv[282]	_	_
21-21	5204-5215	circulating	abstract[282]|abstract[289]	giv[282]|giv[289]	_	_
21-22	5216-5232	oligonucleotides	abstract[282]|abstract[289]	giv[282]|giv[289]	_	_
21-23	5233-5234	,	abstract[282]	giv[282]	_	_
21-24	5235-5244	microRNAs	abstract[282]|animal	giv[282]|new	_	_
21-25	5245-5246	,	abstract[282]	giv[282]	_	_
21-26	5247-5250	and	abstract[282]	giv[282]	_	_
21-27	5251-5258	content	abstract[282]|substance[291]	giv[282]|new[291]	_	_
21-28	5259-5261	in	abstract[282]|substance[291]	giv[282]|new[291]	_	_
21-29	5262-5275	microvesicles	abstract[282]|substance[291]|animal	giv[282]|new[291]|new	_	_
21-30	5276-5282	remain	_	_	_	_
21-31	5283-5293	unexplored	_	_	_	_
21-32	5294-5295	.	_	_	_	_
